Phase 2b, Multicenter, Randomized, Double Blind, Titration Trial for Efficacy and Safety of HDV Insulin Lispro in Combination With a Basal Insulin Versus Insulin Lispro in Combination With a Basal Insulin in Patients With Type 1 Diabetes
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ISLE-1
- Sponsors Diasome Pharmaceuticals
- 01 Feb 2018 Planned End Date changed from 1 Feb 2018 to 15 Jun 2018.
- 01 Feb 2018 Planned primary completion date changed from 1 Nov 2017 to 28 Feb 2018.
- 08 Aug 2017 Status changed from recruiting to active, no longer recruiting.